Search Results - "Jeayeon Park"
-
1
Establishment and characterization of mouse metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma organoids
Published in Scientific reports (10-11-2024)“…Metabolic dysfunction-associated steatohepatitis (MASH) is a form of chronic liver inflammation associated with metabolic syndrome, such as obesity and a major…”
Get full text
Journal Article -
2
Fulminant hepatitis and myocarditis associated with varicella zoster virus infection in a kidney transplant recipient: a case report
Published in Clinical transplantation and research (01-09-2022)“…Varicella zoster virus (VZV) infection can follow a virulent course, leading to possible infection-related mortality in immunocompromised hosts. Visceral…”
Get full text
Journal Article -
3
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
Published in Clinical and molecular hepatology (01-07-2024)“…Chronic hepatitis B (CHB) is related to an increased risk of extrahepatic malignancy (EHM), and antiviral treatment is associated with an incidence of EHM…”
Get full text
Journal Article -
4
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
Published in Frontiers in oncology (28-02-2023)“…Although transarterial radioembolization (TARE) using yttrium-90 ( Y) is a treatment option for large hepatocellular carcinoma (HCC), a fraction of patients…”
Get full text
Journal Article -
5
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Published in Clinical and molecular hepatology (01-07-2023)“…Chronic hepatitis B (CHB) is a risk factor for non-Hodgkin lymphoma (NHL). Our recent study suggested that antiviral treatment may reduce the incidence of NHL…”
Get full text
Journal Article -
6
Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
Published in JHEP reports (01-07-2024)“…The association between hepatitis B envelope antigen (HBeAg) seroclearance during long-term nucleos(t)ide analogue (NA) treatment and the risk of…”
Get full text
Journal Article -
7
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
Published in Journal of liver cancer (01-03-2024)“…Atezolizumab plus bevacizumab and lenvatinib are currently available as first-line therapy for the treatment of unresectable hepatocellular carcinoma (HCC);…”
Get full text
Journal Article -
8
COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B
Published in Immune network (01-10-2023)“…Coronavirus disease 2019 (COVID-19) vaccination may non-specifically alter the host immune system. This study aimed to evaluate the effect of COVID-19…”
Get full text
Journal Article -
9
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Published in Clinical and molecular hepatology (01-07-2023)“…Background/Aims: Chronic hepatitis B (CHB) is a risk factor for non-Hodgkin lymphoma (NHL). Our recent study suggested that antiviral treatment may reduce the…”
Get full text
Journal Article -
10
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
Published in Clinical and molecular hepatology (01-07-2024)“…Background/Aims: Chronic hepatitis B (CHB) is related to an increased risk of extrahepatic malignancy (EHM), and antiviral treatment is associated with an…”
Get full text
Journal Article -
11
COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B
Published in Immune network (2023)“…Coronavirus disease 2019 (COVID-19) vaccination may non-specifically alter the host immune system. This study aimed to evaluate the effect of COVID-19…”
Get full text
Journal Article -
12
-
13
TOP-204 Inhibition of sodium-glucose cotransporter-2 and liver-related complications in diabetic patients
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
14
-
15
-
16
WED-221 A novel point-of-care prediction model for steatotic liver disease: based on bioimpedance analysis
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
17
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study
Published in Hepatology (Baltimore, Md.) (01-09-2024)“…No medication has been found to reduce liver-related events. We evaluated the effect of sodium-glucose cotransporter-2 inhibitor (SGLT2i) on liver-related…”
Get full text
Journal Article -
18
WED-120 - Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: a nationwide cohort study
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
19
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: a nationwide cohort study
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
20
FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article